France· FR:69725264
TYAVAX, suspension et solution pour suspension injectable en seringue préremplie. Vaccin de l'hépatite A (inactivé, adsorbé) et typhoïdique polyosidique
A medicinal product containing polyoside capsulaire vi de salmonella typhi (souche ty2) + virus de l'hépatite a souche gbm inactivé adsorbé, registered in France by SANOFI PASTEUR EUROPE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- POLYOSIDE CAPSULAIRE VI DE SALMONELLA TYPHI (SOUCHE TY2) + VIRUS DE L'HÉPATITE A SOUCHE GBM INACTIVÉ ADSORBÉ
- Manufacturer
- SANOFI PASTEUR EUROPE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009360778361 seringue(s) préremplie(s) bicompartimenté(e)(s)/à 2 compartiments en verre de 0,5 ml avec aiguille(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1ae7c22-af39-4fcc-acd5-c052f01308dc GET /v1/drugs/e1ae7c22-af39-4fcc-acd5-c052f01308dc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69725264",
"date_amm": "2003-02-24",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "POLYOSIDE CAPSULAIRE VI DE SALMONELLA TYPHI (SOUCHE TY2) + VIRUS DE L'HÉPATITE A SOUCHE GBM INACTIVÉ ADSORBÉ",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "solution et suspension pour suspension injectable",
"voies_administration": "intramusculaire;sous-cutanée",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about polyoside capsulaire vi de salmonella typhi (souche ty2) + virus de l'hépatite a souche gbm inactivé adsorbé.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.